$Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report$

Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report

Bibliographic Details
Main Authors:	Margaret Corrigan, Geoffrey Haydon, Fiona Thompson, Neil Rajoriya, Claire L Peplow, Stefan G Hubscher, Neil Steven, Gideon M Hirschfield, Matthew J Armstrong
Format:	Article
Language:	English
Published:	Elsevier 2019-05-01
Series:	JHEP Reports
Subjects:	Hepatitis Immunotherapy Infliximab checkpoint
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589555919300084

Similar Items

Real World Outcomes and Hepatotoxicity of Infliximab in the Treatment of Steroid-Refractory Immune-Related Adverse Events
by: Daniel V. Araujo, et al.
Published: (2021-06-01)

Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
by: Robert S. Zhang, et al.
Published: (2021-03-01)

Checkpoint inhibitor induced esophagitis with documented resolution on infliximab
by: Frank W. Chen, et al.
Published: (2020-12-01)

Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
by: Hao Chi Zhang, et al.
Published: (2019-02-01)

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis
by: Hamzah Abu-Sbeih, et al.
Published: (2019-04-01)

Progress in Application of TNF-α Inhibitors in Immune Checkpoint Therapy
by: ZHAO Jianrong, et al.
Published: (2021-04-01)

Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation
by: Victoria A. Chang, et al.
Published: (2018-12-01)

Infliximab induces clinical, endoscopic and histological responses in refractory ulcerative colitis Infliximab induce respuesta clínica, endoscópica e histológica en la colitis ulcerosa refractaria
by: F. Bermejo, et al.
Published: (2004-02-01)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
by: You Lim Kim, et al.
Published: (2014-01-01)

Dramatic response to infliximab in refractory neurosarcoidosis
by: Chintamaneni Sreekanth, et al.
Published: (2010-01-01)

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis
by: Daniel H Johnson, et al.
Published: (2018-10-01)

EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)
by: E.I. Alexeeva, et al.
Published: (2006-03-01)

EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)
by: E.I. Alexeeva, et al.
Published: (2006-01-01)

Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
by: Salehzadeh F, et al.
Published: (2019-05-01)

Efficacy of Infliximab Dose Escalation in Patients with Refractory Immunotherapy-Related Colitis: A Case Series
by: Faleck, D.M, et al.
Published: (2022)

Calcineurin inhibitors in steroid and anti‐TNF‐alpha refractory immune checkpoint inhibitor colitis
by: Eva Zhang, et al.
Published: (2021-05-01)

Infliximab‐induced autoimmune hepatitis requiring liver transplantation
by: Frederick Wong, et al.
Published: (2019-11-01)

A real‐world data of Immune checkpoint inhibitors in solid tumors from India
by: Vanita Noronha, et al.
Published: (2021-03-01)

Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis
by: Hassan Riad, et al.
Published: (2013-08-01)

Infliximab Treatment of Refractory Cardiac Sarcoidosis
by: Majid Asawaeer, MD, et al.
Published: (2020-08-01)

Uso de infliximabe na policondrite recidivante Infliximab in relapsing polychondritis
by: Ana Paula Soares de Barros, et al.
Published: (2010-04-01)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
by: Subedi S, et al.
Published: (2019-07-01)

Efficacy of infliximab in treatment of refractory panuveitis associated with Behçet disease
by: Živković Maja, et al.
Published: (2017-01-01)

Progress of Steroids Effect on Efficacy of Immune Checkpoint Inhibitors
by: Guoqiang PAN, et al.
Published: (2019-12-01)

Successful Treatment of an Immune-Mediated Colitis Induced by Checkpoint Inhibitor Therapy in a Patient with Advanced Melanoma
by: Maria Paparoupa, et al.
Published: (2020-10-01)

Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection
by: Ruben C. Hoogeveen, et al.
Published: (2020-03-01)

Tratamento com infliximabe da doença de Behçet ativa Therapy with infliximab in active Behçet's disease
by: Alexandre Wagner Silva de Souza, et al.
Published: (2005-04-01)

The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis
by: Heng-Nan Zhao, et al.
Published: (2021-01-01)

Russian registry of Infliximab.Impact of therapy on the functional status of patients with rheumatoid arthritis
by: V N Amirdzhanova, et al.
Published: (2010-12-01)

MELANOMA CUTÂNEO PRIMÁRIO: COMPLICAÇÃO DE TRATAMENTO COM INFLIXIMAB?
by: Bárbara Fernandes, et al.
Published: (2014-06-01)

Development of Anti-bodies against Infliximab in Iraqi Patients with Rheumatoid Arthritis.
by: Mohammed A. Al-Karkhi, et al.
Published: (2015-10-01)

Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis
by: Florentia Dimitriou, et al.
Published: (2021-06-01)

INFLIXIMAB IN THE TREATMENT OF SEVERE STEROID-REFRACTORY ULCERATIVE COLITIS – A CASE REPORT
by: Darja Urlep, et al.
Published: (2004-04-01)

A case report on dramatic response of refractory panuveitis of Behcet disease to short-term therapy with Infliximab followed by Cellcept
by: Jamileh Moghimi, et al.
Published: (2009-05-01)

Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab Pioderma gangrenoso asociado a colitis ulcerosa: respuesta a infliximab
by: A. López San Román, et al.
Published: (2004-06-01)

Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma
by: Stephanie Sanders, et al.
Published: (2020-04-01)

GOUT – induced by Infliximab?- case report
by: Anca Chiriac, et al.
Published: (2012-10-01)

Infusion reaction to infliximab biosimilar after transitioning from infliximab
by: Reem Kashlan, MPH, et al.
Published: (2021-02-01)

Early infliximab antibody testing does not prevent infusion reactions when reinitiating infliximab
by: Joseph D. Feuerstein
Published: (2016-08-01)

Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor
by: Hanping WANG, et al.
Published: (2019-10-01)

Cannot write session to /tmp/vufind_sessions/sess_h28f1g80ivk8ndqu9ooavqfm02